Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0641418B2 - Cholesterol-lowering substances - Google Patents
[go: Go Back, main page]

JPH0641418B2 - Cholesterol-lowering substances - Google Patents

Cholesterol-lowering substances

Info

Publication number
JPH0641418B2
JPH0641418B2 JP61041187A JP4118786A JPH0641418B2 JP H0641418 B2 JPH0641418 B2 JP H0641418B2 JP 61041187 A JP61041187 A JP 61041187A JP 4118786 A JP4118786 A JP 4118786A JP H0641418 B2 JPH0641418 B2 JP H0641418B2
Authority
JP
Japan
Prior art keywords
cholesterol
lowering
substance
present
wheat bran
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61041187A
Other languages
Japanese (ja)
Other versions
JPS62198620A (en
Inventor
俊明 児玉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Seifun Group Inc
Original Assignee
Nisshin Seifun Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Seifun Group Inc filed Critical Nisshin Seifun Group Inc
Priority to JP61041187A priority Critical patent/JPH0641418B2/en
Publication of JPS62198620A publication Critical patent/JPS62198620A/en
Publication of JPH0641418B2 publication Critical patent/JPH0641418B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は血中コレステロール低下物質に関する。TECHNICAL FIELD The present invention relates to a blood cholesterol lowering substance.

〔従来の技術及びその問題点〕[Conventional technology and its problems]

血液中の脂質には、コレステロール、中性脂肪、リン脂
質、遊離脂肪酸がある。これら脂質はその疏水性のた
め、一般にたん白と結合して存在し、この結合体はリポ
たん白と呼ばれている。一般に、脂質代謝異常はリポた
ん白の質的及び量的異常と理解されている。そして、脂
質の中でも特にコレステロールは動脈硬化に関係が深い
ことが古くから知られており、コレステロールの血中濃
度を低下させるため、種々の薬物が開発されてきてい
る。
Blood lipids include cholesterol, neutral fats, phospholipids, and free fatty acids. Because of their hydrophobicity, these lipids generally exist in association with proteins, and the conjugate is called lipoprotein. Abnormal lipid metabolism is generally understood as a qualitative and quantitative abnormality of lipoprotein. It has long been known that cholesterol among lipids is particularly closely related to arteriosclerosis, and various drugs have been developed in order to lower the blood cholesterol concentration.

一方、最近ダイエタリーフアイバー(又は食物繊維、以
下DFとする)について、その生理作用が注目されてきて
いる。そしてその生理作用として種々の作用があるが、
大腸がん防止作用、血糖低下作用、食物中の毒性物質の
毒性低下作用、便秘の予防及び治療、肥満の予防及び治
療などがある。そして、小麦ふすまはDFの重要な供給源
として脚光をあびてきている。その生理活性として、大
腸がん防止作用、便秘の予防及び治療があげられている
が、コレステロール低下作用は弱いとされている。〔A
m.J.Clin.Nutr.,32,2430〜2434(1979)参照〕。
On the other hand, recently, dietary leaf eye bar (or dietary fiber, hereinafter referred to as DF) has been attracting attention for its physiological action. And there are various actions as its physiological action,
There are colorectal cancer preventive action, blood glucose lowering action, toxicity lowering action of toxic substances in food, prevention and treatment of constipation, prevention and treatment of obesity and the like. And wheat bran has been highlighted as an important source of DF. Its physiological activities include prevention of colon cancer and prevention and treatment of constipation, but its cholesterol lowering effect is said to be weak. 〔A
mJClin.Nutr., 32 , 2430-2434 (1979)].

DFは、従来用いられているコレステロール低下物質が主
に合成した薬物であるのに対し、天然から得られたもの
であるので、合成物質に多く見られる副作用の点からみ
ても、優れたコレステロール低下作用が小麦ふすまに見
い出されるならば、その有用性は極めて大きい。
DF is a naturally synthesized cholesterol-lowering substance, whereas it is a naturally-occurring drug. Therefore, DF is an excellent cholesterol-lowering drug in terms of the side effects often seen in synthetic substances. If an action is found in wheat bran, its utility is extremely great.

〔問題点を解決するための手段〕[Means for solving problems]

本発明者らは、小麦ふすまについてそのコレステロール
低下作用に関して追求した結果、極めて簡単な手段によ
りその目的を達成することが出来ることが分つた。
As a result of pursuing the cholesterol lowering action of wheat bran, the present inventors have found that the objective can be achieved by an extremely simple means.

即ち、本発明は粒度が60メツシユ以下の小麦ふすまよ
りなるコレステロール低下物質に関する。
That is, the present invention relates to a cholesterol lowering substance comprising wheat bran having a particle size of 60 mesh or less.

本発明のコレステロール低下物質の製造には、小麦ふす
まを水洗後風乾し、次に粉砕し、分級して粒度60メツ
シユ以下の区分を採取する。
In the production of the cholesterol-lowering substance of the present invention, wheat bran is washed with water, air-dried, then pulverized and classified to collect a section having a particle size of 60 mesh or less.

本発明のコレステロール低下物質は、動物試験によれ
ば、血中コレステロール低下作用を顕著に示し、その
上、上述した如き便秘の予防などの生理作用を何等損う
ことがない。又、本発明の物質は、小麦ふすまであるた
め、ヒト又は動物に対しても何等有害な副作用を示すこ
とがなく、極めて安全である。
According to the animal test, the cholesterol-lowering substance of the present invention markedly exhibits a blood cholesterol-lowering action, and further, does not impair any physiological actions such as the above-mentioned prevention of constipation. Further, since the substance of the present invention includes wheat bran, it does not show any harmful side effects to humans or animals and is extremely safe.

本発明のコレステロール低下物質は、経口で投与され
る。一般に経口で投与される剤型ならばどんな形態でも
よいが、成可く固体の形が好ましい。例えば、粉末、顆
粒、錠剤、細粒、カプセルなどがあげられ、そのままで
もよいが、従来用いられている製剤用の添加物例えば賦
形剤、結合剤、崩壊剤、充填剤、滑沢剤、着色剤、など
も用いて製剤される。又は、これが本発明の特徴の一つ
であるが、そのような剤型にしなくても、従来食用に供
されるもの例えばパン、ケーキ、クツキー、ビスケツ
ト、マカロニ、スパゲツテイ、そば、うどんなど、その
他の食品例えばマフイン、マツシユドポテト、スナツク
食品、まんじゆう、ピザパイ、もち、チヤーハン、お好
み焼、シユーマイ、かまぼこ、ハンバーク、豆腐、ハ
ム、ソーセージ、飲料、ソース、ケチヤツプ、サラダド
レツシング、ジヤム、ジエリー、アイスクリームなどに
添加して用いることができる。
The cholesterol-lowering substance of the present invention is administered orally. Generally, any dosage form for oral administration can be used, but a solid solid form is preferable. For example, powders, granules, tablets, fine granules, capsules and the like may be used, but they may be used as they are, but conventionally used additives such as excipients, binders, disintegrants, fillers, lubricants, It is also formulated with a coloring agent and the like. Or, although this is one of the features of the present invention, even if it is not made into such a dosage form, it is conventionally used for food, such as bread, cakes, kutsky, biscuit, macaroni, spaghetti, buckwheat, udon, etc. Foods such as muffins, mashed potatoes, snack foods, steamed buns, pizza pies, rice cakes, chewy rice, okonomiyaki, shiyumai, kamaboko, hamburg, tofu, ham, sausage, beverages, sauces, ketchup, salad dressing, jiyam, jelly , Ice cream, etc. can be used.

本発明の物質の摂取量は、多ければ多い程、その効果を
あげることが出来、又何等不都合を生じさせない。例え
ば1日1〜数回、5〜60g好ましくは10〜30g用
いる。
The higher the intake amount of the substance of the present invention, the more effective it is, and no inconvenience occurs. For example, 1 to several times a day, 5 to 60 g, preferably 10 to 30 g are used.

〔実施例〕〔Example〕

次に実施例を示す。 Next, examples will be shown.

実施例1 小麦ふすま水洗後、風乾し次に粉砕機にかけ、粉砕し
た。粉砕したものを空気分級機〔ターボクラシフイフア
イアーTC-15N(日清エンジニアリング製)〕にかけ、分
級した。先ず粉砕物をF-1とし、これをF-2部分(77.5
%)とF-5部分(22.5%)とに分け、F-2部分をさらにF-
4部分(34.2%)とF-5部分(43.3%)とに分けた。各部
分の粒度分布を第1表に示す。
Example 1 Wheat bran was washed with water, air-dried, and then crushed by a crusher. The crushed product was applied to an air classifier [Turbo Classif Ear TC-15N (manufactured by Nisshin Engineering)] for classification. First, the crushed material was designated as F-1, and this was designated as the F-2 portion (77.5
%) And the F-5 part (22.5%), and the F-2 part is further F-
It was divided into 4 parts (34.2%) and F-5 parts (43.3%). The particle size distribution of each part is shown in Table 1.

60メツシユを通過した区分を常法に従いハードカプセ
ルに充填した。
The section that passed 60 mesh was filled in a hard capsule according to a conventional method.

〔効果〕〔effect〕

本発明の物質のコレステロール低下作用を以下の試験に
より示す。
The cholesterol lowering effect of the substance of the present invention is shown by the following tests.

下記の第2表に示される飼料6種類を常法により作成し
た。
Six kinds of feeds shown in Table 2 below were prepared by a conventional method.

即ち、飼料Aは通常のもの、飼料Bは対照のもの、飼料
C及びDは分級しない小麦ふすまを含むもの、飼料E及
びFは60メツシユ以下の小麦ふすまを含むものであ
る。
That is, feed A is a normal feed, feed B is a control, feeds C and D are those containing unclassified wheat bran, and feeds E and F are those containing 60 mesh or less wheat bran.

1区6匹のフイシヤー系オスのラツト(体重約100
g)を用い、自由摂食として上記飼料で2週間飼育し
た。結果を第3表に示す。
6 male rat rats in 1 ward (weight approximately 100
g) was used and fed for 2 weeks with the above-mentioned feed as free feeding. The results are shown in Table 3.

第3表の結果から分る様に、本発明の物質を含有した飼
料では、有意に血中コレステロールが低下し又血中中性
脂肪の低下もみられる。
As can be seen from the results shown in Table 3, the diet containing the substance of the present invention significantly lowers blood cholesterol and blood triglyceride.

本発明の物質は、天然から得られたものであるため、合
成の医薬品に見られ勝ちな有害な副作用を何等呈するこ
とがなく、たとえ多量にしかも長期間にわたつて使用し
ても不都合が殆んど生じないという優れた利点を有す
る。又、前述の如く、食品中に添加して使用することも
出来る。
Since the substance of the present invention is obtained from nature, it does not exhibit any harmful side effects which are often observed in synthetic pharmaceuticals, and even if it is used in a large amount and over a long period of time, there is almost no inconvenience. It has an excellent advantage that it rarely occurs. Further, as described above, it can be used by adding it to food.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】粒度が60メツシユ以下の小麦ふすまより
なるコレステロール低下物質。
1. A cholesterol-lowering substance comprising wheat bran having a particle size of 60 mesh or less.
JP61041187A 1986-02-26 1986-02-26 Cholesterol-lowering substances Expired - Lifetime JPH0641418B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61041187A JPH0641418B2 (en) 1986-02-26 1986-02-26 Cholesterol-lowering substances

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61041187A JPH0641418B2 (en) 1986-02-26 1986-02-26 Cholesterol-lowering substances

Publications (2)

Publication Number Publication Date
JPS62198620A JPS62198620A (en) 1987-09-02
JPH0641418B2 true JPH0641418B2 (en) 1994-06-01

Family

ID=12601411

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61041187A Expired - Lifetime JPH0641418B2 (en) 1986-02-26 1986-02-26 Cholesterol-lowering substances

Country Status (1)

Country Link
JP (1) JPH0641418B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0761952B2 (en) * 1987-01-28 1995-07-05 雪印乳業株式会社 Manufacturing method of refined wheat flour
JP5766192B2 (en) * 2010-08-17 2015-08-19 キリン株式会社 Novel plant-derived immunostimulant

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF FOOD SCIENCE=1977 *
JOURNAL OF FOOD SCIENCE=1978 *

Also Published As

Publication number Publication date
JPS62198620A (en) 1987-09-02

Similar Documents

Publication Publication Date Title
JP3574812B2 (en) Method for producing fat mixture
Truswell Cereal grains and coronary heart disease
RU2197152C2 (en) Method of preparing food compositions, food compositions and products
EP2086348A2 (en) Protein and fiber containing dietary supplement
US5268367A (en) Composition and method for lowering blood level of LDL-cholesterol
WO2012114995A1 (en) Organogel for assisting intake of food for persons with difficulty in swallowing/chewing and food for persons with difficulty in swallowing/chewing
CN103653094B (en) Slimming soup base with blood fat reducing function
JPH11246399A (en) Lipid metabolism improving composition
JP2024026804A (en) Agents to improve fatigue, lack of motivation, or drowsiness
MXPA02004511A (en) Cholesterol reducing stanol compositions, preparation and method of use.
JP4012894B2 (en) Turmeric-containing composition
JPH0641418B2 (en) Cholesterol-lowering substances
US5160736A (en) Composition for prevention or treatment of hypertriglyceridemia
US20190224260A1 (en) Metabolic Syndrome Inhibitor
KR100218235B1 (en) How to produce functional eggs using CLA-containing feed
JP3807464B2 (en) Anti-obesity agent
WO2001087075A1 (en) Bakery product containing large quantity of oil-seeds
JP2012162472A (en) Lipid eliminant
JPH0641417B2 (en) Cholesterol metabolism improving substance
JP2011173813A (en) PPARalpha EXPRESSION PROMOTER
WO2020218381A1 (en) Composition for promoting glp-1 secretion
PRAVALLIKA Improving the nutritive value of Adai by adding rice bran
JP2004244413A (en) Ethanol extract of antitumor agent, health food and miso
JP2010105948A (en) Fatty liver inhibitor
JP6835468B2 (en) Composition for reducing blood cholesterol